Recently, Nanjing Aoluo Biotechnology Co., Ltd., which was built by Chinese medicine Qibede, has a great medicine. mRNA the application for new drug clinical trials of the vaccine project was formally accepted by the State Food and Drug Administration.

The project builds on the early project research and formulation development laboratories to build near.2000 flat protein engineering and mRNA technology platform for vaccine development (including small and pilot tests). During the operation of the project, Qibede responded positively, worked closely with Oro Biology Team, and strictly followed national and industrial regulations, technical specifications, quality acceptance and evaluation standards and Party A's requirements. In order to improve the digitalization and intelligence level of the project, Qibede Company has used self-developed high-quality patented products such as digital high-efficiency air supply outlets, and has made great efforts to build a good industrial ecology from research and development data, research and development and production to product application. In the end, the quality of the project reached a qualified acceptance, and Qibede handed in a satisfactory answer to the owner on schedule and with good quality.

In the future, Chibede will continue to provide high-quality technical services, continue to create value for industry customers, and jointly promote industry progress.

(Contributions by Chinese Medicine Chibede)